Life (Sep 2022)

Ivermectin: A Controversial Focal Point during the COVID-19 Pandemic

  • Manuel Castillejos-López,
  • Luz Maria Torres-Espíndola,
  • Juan Carlos Huerta-Cruz,
  • Edgar Flores-Soto,
  • Bianca S. Romero-Martinez,
  • Rafael Velázquez-Cruz,
  • Anjarath Higuera-Iglesias,
  • Ángel Camarena,
  • Ana Karen Torres-Soria,
  • Citlaltepetl Salinas-Lara,
  • Rosario Fernández-Plata,
  • Noé Alvarado-Vásquez,
  • Héctor Solís-Chagoyán,
  • Víctor Ruiz,
  • Arnoldo Aquino-Gálvez

DOI
https://doi.org/10.3390/life12091384
Journal volume & issue
Vol. 12, no. 9
p. 1384

Abstract

Read online

The SARS-CoV-2 pandemic has confirmed the apocalyptic predictions that virologists have been making for several decades. The challenge the world is facing is that of trying to find a possible treatment, and a viable and expedient option for addressing this challenge is the repurposing of drugs. However, in some cases, although these drugs are approved for use in humans, the mechanisms of action involved are unknown. In this sense, to justify its therapeutic application to a new disease, it is ideal, but not necessary, to know the basic mechanisms of action involved in a drug’s biological effects. This review compiled the available information regarding the various effects attributed to Ivermectin. The controversy over its use for the treatment of COVID-19 is demonstrated by this report that considers the proposal unfeasible because the therapeutic doses proposed to achieve this effect cannot be achieved. However, due to the urgent need to find a treatment, an exhaustive and impartial review is necessary in order to integrate the knowledge that exists, to date, of the possible mechanisms through which the treatment may be helpful in defining safe doses and schedules of Ivermectin.

Keywords